The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Chemokines as Mediators of Neovascularization
Open accessAbstract
Chemokines are a superfamily of homologous heparin-binding proteins, first described for their role in recruiting leukocytes to sites of inflammation. Chemokines have since been recognized as key factors mediating both physiological and pathological neovascularization in such diverse clinical settings as malignancy, wound repair, chronic fibroproliferative disorders, myocardial ischemia, and atherosclerosis. Members of the CXC chemokine family, structurally defined as containing the ELR amino acid motif, are potent inducers of angiogenesis, whereas another subset of the CXC chemokines inhibits angiogenesis. In addition, CCL2, a CC chemokine ligand, has been implicated in arteriogenesis. In this article, we review the current literature on the role of chemokines as mediators of neovascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CXCL9 also inhibits neovascularization (83) and has anti-tumor and anti-metastatic effects (74).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [83]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“CXCL10, or interferon gamma-induced protein 10, is secreted not only by monocytes and macrophages, but also by fibroblasts and endothelial cells (83).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,633
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,263
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 2,011
Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001886 · Cited by 1,610
Risau, W., & Flamme, I. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.000445 · Cited by 1,410
Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., & Leung, D. W. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1806 · Cited by 1,364
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.3.963 · Cited by 1,333
Atherosclerotic Plaque Progression and Vulnerability to Rupture
Virmani, R., Kolodgie, F. D., BURKE, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,326
Lymphocyte traffic control by chemokines
Moser, B., & Loetscher, P. (2001) · Nature Immunology · doi:10.1038/84219 · Cited by 1,253
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Self-citationYamaguchi, J.-I., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch‐Marcé, M., Masuda, H., Losordo, D. W., Isner, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055313.77510.22 · Cited by 1,149
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory Cells
Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Yung, S., Chimenti, S., Landsman, L., Abramovitch, R., & Keshet, E. (2006) · Cell · doi:10.1016/j.cell.2005.10.036 · Cited by 1,125
Chemokines in cutaneous wound healing
Gillitzer, R., & Goebeler, M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.4.513 · Cited by 943
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 860
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 822
Self-citationDewald, O., Zymek, P. T., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 741
Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 740
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 698
The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation
Munro, J. M., & Cotran, R. S. (1989) · Humana Press eBooks · doi:10.1007/978-1-4612-4502-5_10 · Cited by 698
Addison, C., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y., Buechi, L., Walz, A., Richmond, A. J., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 582
Self-citationSalcedo, R., Wasserman, K., Young, H. A., Grimm, M., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 548
FALCO, E. D., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4423 · Cited by 519
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., Smith, C. W., Enamorado, I. I., Yeh, N. T., Kroog, G. S., Rudy, S., et al. (1999) · PubMed · Cited by 486
Joris, I., Zand, T., Nunnari, J. J., Krolikowski, F. J., & Majno, G. (1983) · PubMed Central · Cited by 478
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lügering, N., Domschke, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208231200 · Cited by 478
Sluimer, J. C., Gasc, J., van Wanroij, J. L., Kisters, N., Groeneweg, M., Gelpke, M. D. S., Cleutjens, J. P. M., van den Akker, L. H. J. M., Corvol, P. L., Wouters, B. G., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.12.025 · Cited by 472
Ito, W. D., Arras, M., Winkler, B. E., Scholz, D., Schaper, J., & Schaper, W. K. A. (1997) · Circulation Research · doi:10.1161/01.res.80.6.829 · Cited by 470
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 468
Self-citationIntussusceptive angiogenesis: Its emergence, its characteristics, and its significance
Burri, P. H., Hlushchuk, R., & Djonov, V. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20184 · Cited by 436
Delayed Wound Healing in CXCR2 Knockout Mice
Devalaraja, R. M., Nanney, L. B., Qian, Q., Du, J., Yu, Y., Devalaraja, M. N., & Richmond, A. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00034.x · Cited by 429
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., & Strieter, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118734 · Cited by 404
Self-citationThe CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
Keane, M. P., Arenberg, D. A., Lynch, J. P., Whyte, R. I., Iannettoni, M. D., Burdick, M. D., Wilke, C. A., Morris, S. B., Glass, M., DiGiovine, B., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1437 · Cited by 382
Self-citationHong, K. H., Ryu, J., & Han, K. H. (2004) · Blood · doi:10.1182/blood-2004-08-3178 · Cited by 382
Dewald, O., Ren, G., Duerr, G. D., Zoerlein, M., Klemm, C., Gersch, C. M., Tincey, S., Michael, L. H., Entman, M. L., & Frangogiannis, N. G. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63154-9 · Cited by 382
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 377
Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice
Yoneda, J., Kuniyasu, H., Price, J. E., Bucana, C. D., Fidler, I. J., & Crispens, M. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.447 · Cited by 375
Factors Regulating Arteriogenesis
Schaper, W. K. A., & Scholz, D. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000069625.11230.96 · Cited by 368
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., & Strieter, R. M. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.5.1409 · Cited by 368
Self-citationSingh, R. K., Gutman, M., Radinsky, R., BUCANA, C. D., & Fidler, I. J. (1994) · PubMed · Cited by 360
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M., Taub, D. D., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.3.981 · Cited by 356
Self-citationFujiyama, S., Amano, K., Uehira, K., Yoshida, M., Nishiwaki, Y., Nozawa, Y., Jin, D., Takai, S., Miyazaki, M., Egashira, K., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000099245.08637.ce · Cited by 356
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis
Garkavtsev, I., Kozin, S. V., Chernova, O. B., Xu, L., Winkler, F., Brown, E. B., Barnett, G. H., & Jain, R. K. (2004) · Nature · doi:10.1038/nature02329 · Cited by 353
Djonov, V., Schmid, M. C., Tschanz, S. A., & Burri, P. H. (2000) · Circulation Research · doi:10.1161/01.res.86.3.286 · Cited by 342
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
Wang, D., Wang, H., Brown, J. R., Daikoku, T., Wei, N., Shi, Q., Richmond, A. J., Strieter, R. M., Dey, S. K., & DuBois, R. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052124 · Cited by 337
Self-citationTherapeutic angiogenesis in cardiovascular disease
Simons, M., & Ware, J. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1226 · Cited by 328
Angiogenesis in ischemic heart disease
Ware, J. A., & Simons, M. (1997) · Nature Medicine · doi:10.1038/nm0297-158 · Cited by 326
Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease
van Royen, N. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00206-6 · Cited by 326
Arteriogenesis The Development and Growth of Collateral Arteries
Helisch, A., & Schaper, W. K. A. (2003) · Microcirculation · doi:10.1038/sj.mn.7800173 · Cited by 312
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 312
Self-citationChen, J. J. W., Yao, P., Yuan, A., Hong, T.-M., Shun, C., Kuo, M., Lee, Y.-C., & Yang, P. (2003) · PubMed · Cited by 309
Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.927 · Cited by 295
Stellos, K., Langer, H. F., Daub, K., Schoenberger, T., Gauß, A., Geisler, T., Bigalke, B., Mueller, I. I., Schumm, M., Schaefer, I., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.714691 · Cited by 291
Frangogiannis, N. G., Dewald, O., Xia, Y., Ren, G., Haudek, S. B., Leucker, T. M., Kraemer, D., Taffet, G. E., Rollins, B. J., & Entman, M. L. (2007) · Circulation · doi:10.1161/circulationaha.106.646091 · Cited by 289
Expression of CCR2 by Endothelial Cells
Weber, K. S. C., Nelson, P. J., Gröne, H., & Weber, C. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2085 · Cited by 280
CXC CHEMOKINE RECEPTOR EXPRESSION ON HUMAN ENDOTHELIAL CELLS
Murdoch, C., Monk, P. N., & Finn, A. H. R. (1999) · Cytokine · doi:10.1006/cyto.1998.0465 · Cited by 273
Rabin, R. L., Park, M. K., Liao, F., Swofford, R., Stephany, D., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3840 · Cited by 266
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.
Kitadai, Y., Haruma, K., Sumii, K., Yamamoto, S., Ue, T., Yokozaki, H., Yasui, W., Ohmoto, Y., Kajiyama, G., Fidler, I. J., et al. (1998) · Europe PMC (PubMed Central) · Cited by 265
Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells
Salcedo, R., Young, H. A., Ponce, M. L., Ward, J. M., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7571 · Cited by 259
Arenberg, D. A., Keane, M. P., DiGiovine, B., Kunkel, S. L., Morris, S. B., Xue, Y. Y., Burdick, M. D., Glass, M. C., Iannettoni, M. D., & Strieter, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3145 · Cited by 259
Self-citationHristov, M., Zernecke, A., Bidzhekov, K., Liehn, E. A., Shagdarsuren, E., Ludwig, A., & Weber, C. (2007) · Circulation Research · doi:10.1161/01.res.0000259043.42571.68 · Cited by 253
Salcedo, R., Resau, J. H., Halverson, D. O., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 244
Keane, M. P., Belperio, J. A., Moore, T. A., Moore, B. B., Arenberg, D. A., Smith, R. E., Burdick, M. D., Kunkel, S. L., & Strieter, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5511 · Cited by 241
Self-citationPrecapillary Systemic-pulmonary Anastomoses
Turner-Warwick, M. E. H. (1963) · Thorax · doi:10.1136/thx.18.3.225 · Cited by 241
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J. A., & Zlotnik, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8205 · Cited by 238
Self-citationKeane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z., Xue, Y., & Strieter, R. M. (1999) · PubMed · Cited by 232
Self-citationHeil, M., Ziegelhoeffer, T., Wagner, S. R., Fernández, B., Helisch, A., Martin, S. M., Tribulova, S., Kuziel, W. A., Bachmann, G. F., & Schaper, W. K. A. (2004) · Circulation Research · doi:10.1161/01.res.0000122041.73808.b5 · Cited by 227
IL-8 Is an Angiogenic Factor in Human Coronary Atherectomy Tissue
Simonini, A. A., Moscucci, M. M., Muller, D. W., Bates, E., Pagani, F. D., Burdick, M. D., & Strieter, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1519 · Cited by 225
Self-citationMyocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
Damås, J. K. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00142-5 · Cited by 218
Niu, J., Azfer, A., Zhelyabovska, O., Fatma, S., & Kolattukudy, P. E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802139200 · Cited by 218
Chemokines as mediators of angiogenesis
Mehrad, B., Keane, M. P., & Strieter, R. M. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-01-0040 · Cited by 217
Self-citationKeane, M. P., Belperio, J. A., Arenberg, D. A., Burdick, M. D., Xu, Z., Xue, Y., & Strieter, R. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5686 · Cited by 212
Self-citationKim, S. J., Uehara, H., Karashima, T., Mccarty, M., Shih, N., & Fidler, I. J. (2001) · Neoplasia · doi:10.1038/sj.neo.7900124 · Cited by 207
Luan, J. Y., Shattuck-Brandt, R. L., Haghnegahdar, H., Owen, J. D., Strieter, R. M., Burdick, M. D., Nirodi, C. S., Beauchamp, D., Johnson, K. N., & Richmond, A. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.588 · Cited by 205
Self-citationSecondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo
Sharma, S. P., Stolina, M., Luo, J., Strieter, R. M., Burdick, M. D., Zhu, L. X., Batra, R. K., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4558 · Cited by 204
Self-citationGengrinovitch, S., Greenberg‐Sepersky, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T. E., Levi, B.-Z., & Neufeld, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15059 · Cited by 203
Distinct CXC Chemokines Mediate Tumorigenicity of Prostate Cancer Cells
Moore, B. B., Arenberg, D. A., Stoy, K., Morgan, T., Addison, C., Morris, S. B., Glass, M., Wilke, C. A., Xue, Y., Sitterding, S. M., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65404-1 · Cited by 201
Self-citationArteriogenesis The Development and Growth of Collateral Arteries
Helisch, A., & Schaper, W. K. A. (2003) · Microcirculation · doi:10.1080/mic.10.1.83.97 · Cited by 200
Chemokine/chemokine receptor nomenclature
Nomenclature, I. S. O. C. (2003) · Cytokine · doi:10.1016/s1043-4666(02)00493-3 · Cited by 198
Nickoloff, B. J., Mitra, R. S., Varani, J., Dixit, V. M., & Polverini, P. J. (1994) · PubMed Central · Cited by 186
Therapeutic angiogenesis and vasculogenesis for tissue regeneration
Madeddu, P. R. (2005) · Experimental Physiology · doi:10.1113/expphysiol.2004.028571 · Cited by 185
CCL2 Regulates Angiogenesis via Activation of Ets-1 Transcription Factor
Stamatovic, S. M., Keep, R. F., Mostarica‐Stojković, M., & Andjelkovic, A. V. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2651 · Cited by 177
CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y., Zisman, D. A., Belperio, J. A., & Strieter, R. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1164oc · Cited by 170
Self-citationPerollet, C., Han, Z., Savona‐Baron, C., Caen, J., & Bikfalvi, A. (1998) · Blood · doi:10.1182/blood.v91.9.3289 · Cited by 169
Wislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., CODY, D. D., Langley, R. R., Tang, H., Burdick, M. D., Sato, M., Minna, J. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3842 · Cited by 165
Self-citationStruyf, S., Burdick, M. D., Proost, P., Damme, J. V., & Strieter, R. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146674.38319.07 · Cited by 163
Self-citationPost-ischaemic neovascularization and inflammation
Silvestre, J., Mallat, Z., Tedgui, A., & Levy, B. I. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn027 · Cited by 155
Ehlert, J. E., Addison, C. A., Burdick, M. D., Kunkel, S. L., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6234 · Cited by 147
Self-citationThe Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma
Mestas, J., Burdick, M. D., Reckamp, K. L., Pantuck, A. J., Figlin, R. A., & Strieter, R. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5351 · Cited by 145
Self-citationPlatelet Factor 4: An Inhibitor of Angiogenesis
Bikfalvi, A. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-831051 · Cited by 144
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Wente, M. N., Keane, M. P., Burdick, M. D., Frieß, H., Büchler, M. W., Ceyhan, G. O., Reber, H. A., Strieter, R. M., & Hines, O. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.10.041 · Cited by 142
Self-citationKocher, A. A., Schuster, M., Bonaros, N. E., Lietz, K., Xiang, G., Martens, T. P., Kurlansky, P. A., Sondermeijer, H. P., Witkowski, P., & Boyle, A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.11.013 · Cited by 142
Autocrine Growth Effect of IL-8 and GRO?? on a Human Pancreatic Cancer Cell Line, Capan-1
Takamori, H., Oades, Z. G., Hoch, R. C., Burger, M., & Schraufstätter, I. U. (2000) · Pancreas · doi:10.1097/00006676-200007000-00051 · Cited by 141
MILLER, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., & Kreutzer, D. L. (1998) · PubMed · Cited by 141
White, E. S., Flaherty, K. R., Carskadon, S. L., Brant, A., Iannettoni, M. D., Yee, J., Orringer, M. B., & Arenberg, D. A. (2003) · PubMed · Cited by 140
The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth
Shen, H., Schuster, R. M., Stringer, K. F., Waltz, S. E., & Lentsch, A. B. (2006) · The FASEB Journal · doi:10.1096/fj.05-4764com · Cited by 139
Wright, K., Wilson, P. J., Morland, S. J., Campbell, I., Walsh, M. D., Hurst, T., Ward, B. G., Cummings, M. C., & Chenevix‐Trench, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5 · Cited by 134
Chemokines in Myocardial Ischemia
Frangogiannis, N. G., & Entman, M. L. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.06.005 · Cited by 128
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Gomperts, B. N., Xue, Y., Hong, K. M., Mestas, J., Ardehali, A. A., Mehrad, B., Saggar, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24233 · Cited by 126
Self-citationCXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis
Pan, J., Burdick, M. D., Belperio, J. A., Xue, Y., Gerard, C. J., Sharma, S. P., Dubinett, S. M., & Strieter, R. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1456 · Cited by 123
Self-citationTumor-associated angiogenesis in prostate cancer.
FREGENE, T., Khanuja, P. S., Noto, A. C., Gehani, S., Egmont, E. M. V., Luz, D. A., & Pienta, K. J. (1993) · PubMed · Cited by 120
Beider, K., Nagler, A., Wald, O., Franitza, S., Dagan‐Berger, M., Wald, H., Giladi, H., Brocke, S., Hanna, J. H., Mandelboim, O., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3293 · Cited by 117
The interaction of platelet factor four and glycosaminoglycans
Loscalzo, J., Melnick, B., & Handin, R. I. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90049-9 · Cited by 117
Yang, J., & Richmond, A. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.01.010 · Cited by 115
Dudek, A. Z., Nesmelova, I. V., Mayo, K. H., Verfaillie, C. M., Pitchford, S. C., & Slungaard, A. (2003) · Blood · doi:10.1182/blood-2002-08-2363 · Cited by 114
Lakshminarayanan, V., Lewallen, M., Frangogiannis, N. G., Evans, A. J., Wedin, K. E., Michael, L. H., & Entman, M. L. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62517-5 · Cited by 113
Gupta, S. K., & Singh, J. P. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.4.1121 · Cited by 112
Frangogiannis, N. G., Mendoza, L. H., Lewallen, M., Michael, L. H., Smith, C. W., & Entman, M. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0745fje · Cited by 111
Inhibition of In Vitro Angiogenesis by Platelet Factor-4–Derived Peptides and Mechanism of Action
Jouan–Hureaux, V., Canron, X., Alemany, M., Caen, J., Quentin, G., Plouët, J., & Bikfalvi, A. (1999) · Blood · doi:10.1182/blood.v94.3.984.415k31_984_993 · Cited by 110
Struyf, S., Burdick, M. D., Peeters, E., den Broeck, K. V., Dillen, C., Proost, P., Damme, J. V., & Strieter, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4682 · Cited by 106
Self-citationNeoformation of blood vessels in association with rat lung fibrosis induced by bleomycin
Peão, M. N. D., Águas, A. P., Sá, C., & Grande, N. R. (1994) · The Anatomical Record · doi:10.1002/ar.1092380108 · Cited by 104
Gálvez, B. G., Genı́s, L., Matı́as-Román, S., Oblander, S. A., Tryggvason, K., Apte, S., & Arroyo, A. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408673200 · Cited by 103
Addison, C., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-28 · Cited by 101
Self-citationCoexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
Richards, B. L., Eisma, R. J., Spiro, J. D., Lindquist, R. L., & Kreutzer, D. L. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00165-7 · Cited by 100
Interleukin-8 Expression by Head and Neck Squamous Cell Carcinoma
Cohen, R., Contrino, J., Spiro, J. D., MANN, E. A., Chen, L. L., & Kreutzer, D. L. (1995) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1995.01890020064013 · Cited by 100
CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer
Strieter, R. M., Belperio, J. A., Burdick, M. D., Sharma, S. P., Dubinett, S. M., & Keane, M. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1322.041 · Cited by 99
Self-citationCCL16 activates an angiogenic program in vascular endothelial cells
Strasly, M. (2003) · Blood · doi:10.1182/blood-2003-05-1387 · Cited by 92
Studies on the Pathogenesis of Atherosclerosis [ Abridged ]
WALTON, K. W. (1969) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576906200430 · Cited by 90
Wilkes, D. S., Egan, T. M., & Reynolds, H. Y. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-098ws · Cited by 88
Yatsunami, J., Tsuruta, N., Ogata, K., Wakamatsu, K., Takayama, K., Kawasaki, M., Nakanishi, Y., Hara, N., & Hayashi, S.-I. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00296-6 · Cited by 85
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
Sharma, S. P., Yang, S.-C., Hillinger, S., Zhu, L. X., Huang, M., Batra, R. K., Lin, J. F.-H., Burdick, M. D., Strieter, R. M., & Dubinett, S. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-22 · Cited by 83
Self-citationNanney, L. B., Mueller, S. G., Bueno, R., Peiper, S. C., & Richmond, A. J. (1995) · Europe PMC (PubMed Central) · Cited by 82
Barcelos, L. S., Talvani, A., Teixeira, A. S., Cassali, G. D., Andrade, S. P., & Teixeira, M. M. (2004) · Inflammation Research · doi:10.1007/s00011-004-1299-4 · Cited by 77
Microvessel density in prostate cancer: prognostic and therapeutic utility.
Bostwick, D. G., & Iczkowski, K. A. (1998) · PubMed · Cited by 73
Fowler, S., Berberian, P. A., Shio, H., Goldfischer, S. L., & Wolinsky, H. (1980) · Circulation Research · doi:10.1161/01.res.46.4.520 · Cited by 70
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme
Charalambous, C., Chen, T. C., & Hofman, F. M. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.4.e22 · Cited by 69
Du, J., Luan, J. Y., Liu, H., Daniel, T. O., Peiper, S. C., Chen, T. S., Yu, Y., Horton, L. W., Nanney, L. B., Strieter, R. M., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.1.141 · Cited by 67
Self-citationRegulation of Th1/Th2 Development by Antigen-Presenting Cells in vivo
Moser, M. (2001) · Immunobiology · doi:10.1078/0171-2985-00092 · Cited by 64
Sulpice, E., Bryckaert, M., Lacour, J., Contrerès, J.-O., & Tobelem, G. (2002) · Blood · doi:10.1182/blood.v100.9.3087 · Cited by 63
Keane, M. P., Donnelly, S. C., Belperio, J. A., Goodman, R. B., Dy, M. C., Burdick, M. D., Fishbein, M. C., & Strieter, R. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6515 · Cited by 60
Self-citationHow Do Chemokine/Chemokine Receptor Activations Affect Tumorigenesis?
Richmond, A. J., Fan, G.-H., Dhawan, P., & Yang, J. (2004) · Novartis Foundation symposium · doi:10.1002/0470856734.ch6 · Cited by 44
Angiogenic activity and interleukin-8 content of human ovarian cancer ascites.
Gawrychowski, K., Skopińska-Różewska, E., Barcz, E., Sommer, E., Szaniawska, B., Roszkowska‐Purska, K., Janik, P., & Zielinski, J. (1998) · PubMed · Cited by 43
Bikfalvi, A., & Giménez‐Gallego, G. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-822978 · Cited by 37
SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation
Guerin, E., Sheridan, C., Assheton, D., Kent, D. L., Wong, D., Grant, M. B., & Hiscott, P. S. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.12.001 · Cited by 29
Ramakrishna, V., Negri, D. R. M., Brusić, V., Fontanelli, R., Canevari, S., Bolis, G., Castelli, C., & Parmiani, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1 · Cited by 26
Zimmermann, R., Arras, M., Ullmann, C., Strasser, R., Sack, S., Mollnau, H., Schaper, J., & Schaper, W. K. A. (1997) · Cell and Tissue Research · doi:10.1007/s004410050781 · Cited by 20
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Self-citationShort peptides sensitize target cells to CTL specific for the MHC class Ib molecule, H2-M3
Dabhi, V. M., & Fischer Lindahl, K. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11
Cited by
Sorted by citations
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
“CXCL10 (IP-10) CXCL10, or interferon gamma-induced protein 10, is secreted not only by monocytes and macrophages, but also by fibroblasts and endothelial cells (83).”
BackgroundChemokines in health and disease
Raman, D., Sobolik-Delmaire, T., & Richmond, A. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.01.005 · Cited by 387
Comprehensive Analysis of Inflammatory Immune Mediators in Vitreoretinal Diseases
Yoshimura, T., Sonoda, K., Sugahara, M., Mochizuki, Y., Enaida, H., Oshima, Y., Ueno, A., Hata, Y., Yoshida, H., & Ishibashi, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008158 · Cited by 349
Extracellular matrix, inflammation, and the angiogenic response
Arroyo, A. G., & Iruela‐Arispe, M. L. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq049 · Cited by 353
CXC Chemokines in Cancer Angiogenesis and Metastases
Keeley, E. C., Mehrad, B., & Strieter, R. M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)06003-3 · Cited by 263
Self-citation
Metadata
- Authors
- Keeley, E. C., Mehrad, B., & Strieter, R. M.
- Affiliations
- University of Virginia (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2008-11
- Volume
- 28
- Issue
- 11
- Pages
- 1928-1936
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- PMC
- PMC2735456
- OpenAlex
- W2125050685
- Cited by
- 192
- References
- 142
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 10 · 2021: 17 · 2020: 7 · 2019: 6 · 2018: 12 · 2017: 7 · 2016: 6 · 2015: 14 · 2014: 12 · 2013: 15 · 2012: 19
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL66027, HL-73848, R01HL066027, R01HL073848)
- National Cancer Institute (CA-87879, R01CA087879)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- chemokines, neovascularization, angiogenesis, arteriogenesis, CXC chemokines, CC chemokines, MCP-1, inflammation, wound healing, atherosclerosis, myocardial ischemia, fibroproliferative disorders, cancer
- MeSH terms
- Animals, Humans, Neovascularization, Pathologic, Neovascularization, Physiologic, Chemokines, Angiogenic Proteins, Endothelial Cells, Angiostatic Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review